FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996012005> ?p ?o ?g. }

• W1996012005 endingPage "5109" @default.
• W1996012005 startingPage "5109" @default.
• W1996012005 abstract "Purpose.: Extracellular matrix (ECM) and cellular membrane proteoglycans (PGs) play important roles in neural differentiation and cell adhesion. Vascular endothelial growth factor, an important signal protein in vascular and retinal neural cell development, is retained in the ECM due to its high affinity for PG. Bevacizumab, an anti-VEGF agent, has been extensively used for treating retinal diseases in adult and newborn patients, although its effect on the developing retina remains largely unknown. The purpose of this study was to investigate the effect of bevacizumab on neurocan, phosphacan, and syndecan-3 PG levels in newborn rat retina. Methods.: Retinal explants of sixty 2-day-old Lister hooded rats were obtained after eye enucleation and maintained in culture media with or without bevacizumab for 48 hours. Immunohistochemical staining was assessed against neurocan, phosphacan, and syndecan-3. Proteoglycan content was quantified based on the intensity of immunohistochemical labeling. Gene expressions were quantified by real-time reverse-transcription polymerase chain reaction. The results from the treatment and control groups were compared. Results.: No significant difference in the staining intensity and mRNA expression of phosphacan and syndecan-3 was observed between the groups. However, a significant decrease in neurocan content and mRNA expression was observed in bevacizumab-treated retinal explants compared with controls. Conclusions.: Bevacizumab did not affect phosphacan and syndecan-3 levels but decreased neurocan content and gene expression. Therefore, it may interfere with early postnatal retinal cell differentiation. Although further studies are necessary to confirm our findings, we suggest anti-VEGF agents be used with caution in developing retinal tissue." @default.
• W1996012005 created "2016-06-24" @default.
• W1996012005 creator A5020464766 @default.
• W1996012005 creator A5022411560 @default.
• W1996012005 creator A5027585180 @default.
• W1996012005 creator A5031629624 @default.
• W1996012005 creator A5045241708 @default.
• W1996012005 creator A5053137535 @default.
• W1996012005 creator A5057546103 @default.
• W1996012005 creator A5068471593 @default.
• W1996012005 date "2014-08-18" @default.
• W1996012005 modified "2023-10-16" @default.
• W1996012005 title "Bevacizumab Reduces Neurocan Content and Gene Expression in Newborn Rat Retina In Vitro" @default.
• W1996012005 cites W1484827186 @default.
• W1996012005 cites W1514628637 @default.
• W1996012005 cites W1539571840 @default.
• W1996012005 cites W1552174856 @default.
• W1996012005 cites W1579034041 @default.
• W1996012005 cites W1590819389 @default.
• W1996012005 cites W1598171890 @default.
• W1996012005 cites W1624346216 @default.
• W1996012005 cites W1698768292 @default.
• W1996012005 cites W1965259073 @default.
• W1996012005 cites W1969249989 @default.
• W1996012005 cites W1978094522 @default.
• W1996012005 cites W1979518563 @default.
• W1996012005 cites W1982533441 @default.
• W1996012005 cites W1983805190 @default.
• W1996012005 cites W1985712533 @default.
• W1996012005 cites W1987592240 @default.
• W1996012005 cites W1988233478 @default.
• W1996012005 cites W1991012961 @default.
• W1996012005 cites W2000292756 @default.
• W1996012005 cites W2007121200 @default.
• W1996012005 cites W2009673528 @default.
• W1996012005 cites W2014022936 @default.
• W1996012005 cites W2015843817 @default.
• W1996012005 cites W2016459748 @default.
• W1996012005 cites W2024725915 @default.
• W1996012005 cites W2027538443 @default.
• W1996012005 cites W2029126623 @default.
• W1996012005 cites W2034663345 @default.
• W1996012005 cites W2037139745 @default.
• W1996012005 cites W2047572109 @default.
• W1996012005 cites W2051193332 @default.
• W1996012005 cites W2053866194 @default.
• W1996012005 cites W2060121015 @default.
• W1996012005 cites W2067626374 @default.
• W1996012005 cites W2074988828 @default.
• W1996012005 cites W2075785827 @default.
• W1996012005 cites W2082054044 @default.
• W1996012005 cites W2085292494 @default.
• W1996012005 cites W2085366579 @default.
• W1996012005 cites W2085721499 @default.
• W1996012005 cites W2090295661 @default.
• W1996012005 cites W2098974321 @default.
• W1996012005 cites W2113170046 @default.
• W1996012005 cites W2120471129 @default.
• W1996012005 cites W2122595579 @default.
• W1996012005 cites W2137667222 @default.
• W1996012005 cites W2142509200 @default.
• W1996012005 cites W2159764938 @default.
• W1996012005 cites W2166086027 @default.
• W1996012005 cites W2166926836 @default.
• W1996012005 cites W2468408469 @default.
• W1996012005 cites W35627396 @default.
• W1996012005 doi "https://doi.org/10.1167/iovs.14-14466" @default.
• W1996012005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25061112" @default.
• W1996012005 hasPublicationYear "2014" @default.
• W1996012005 type Work @default.
• W1996012005 sameAs 1996012005 @default.
• W1996012005 citedByCount "6" @default.
• W1996012005 countsByYear W19960120052017 @default.
• W1996012005 countsByYear W19960120052018 @default.
• W1996012005 countsByYear W19960120052020 @default.
• W1996012005 countsByYear W19960120052022 @default.
• W1996012005 countsByYear W19960120052023 @default.
• W1996012005 crossrefType "journal-article" @default.
• W1996012005 hasAuthorship W1996012005A5020464766 @default.
• W1996012005 hasAuthorship W1996012005A5022411560 @default.
• W1996012005 hasAuthorship W1996012005A5027585180 @default.
• W1996012005 hasAuthorship W1996012005A5031629624 @default.
• W1996012005 hasAuthorship W1996012005A5045241708 @default.
• W1996012005 hasAuthorship W1996012005A5053137535 @default.
• W1996012005 hasAuthorship W1996012005A5057546103 @default.
• W1996012005 hasAuthorship W1996012005A5068471593 @default.
• W1996012005 hasBestOaLocation W19960120051 @default.
• W1996012005 hasConcept C167734588 @default.
• W1996012005 hasConcept C169760540 @default.
• W1996012005 hasConcept C185592680 @default.
• W1996012005 hasConcept C2777025900 @default.
• W1996012005 hasConcept C2777093970 @default.
• W1996012005 hasConcept C2780827179 @default.
• W1996012005 hasConcept C502942594 @default.
• W1996012005 hasConcept C55493867 @default.
• W1996012005 hasConcept C86803240 @default.
• W1996012005 hasConcept C95444343 @default.
• W1996012005 hasConceptScore W1996012005C167734588 @default.

• next